Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV
Completed · Not applicable
Conditions studied: Insulin Resistance, Cardiovascular Diseases, Heart Diseases, HIV Infections, Hypertriglyceridemia, Hyperlipidemia
In brief
The purpose of this study is to test whether chronic administration of the drug acipimox will improve hyperlipidemia and insulin sensitivity among HIV infected patients experiencing highly active antiretroviral therapy (HAART) associated metabolic disturbances.
Key facts
- Study ID
- NCT00246402
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
- People needed
- 30
- Starts
- 2002-09-01
- Expected to finish
- 2006-08-01
- Last updated by the study team
- 2014-05-15
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Documented HIV infection
- Stable antiretroviral regimen for greater than 3 months
- Hypertriglyceridemia (fasting triglycerides greater than 150mg/dl)
- Evidence of fat redistribution (e.g., increased abdominal or cervical fat, and/or decreased subcutaneous fat of the face, arms, or legs) on physical exam
You may not qualify if…
- Current therapy with a lipid lowering medication (e.g., fibrates, HMG CoA reductase inhibitors, resins) or treatment with these agents in the 3 months prior to study entry
- Current use of hormone replacement therapy, oral contraceptives for women, or supraphysiologic testosterone therapy in men
- Fasting triglycerides greater than 1000mg/dl
- Active alcohol or substance abuse
- Active peptic ulcer disease
- History of renal failure or serum creatinine greater than 2.0
- Serious opportunistic infection within the 3 months prior to study entry
- Hemoglobin less than 11.0 mg/dl
- Elevated transaminase levels (AST or ALT greater than 2.5x the upper limit of normal)
- Previously diagnosed diabetes mellitus or patients receiving current treatment for diabetes
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.